Evaluation of run-out cancer cells during laparoscopic surgery in hepato-biliary pancreatic diseases

Evaluation of run-out cancer cells during laparoscopic surgery in hepato-biliary pancreatic diseases - Evaluation of run-out cancer cells during laparoscopic surgery in hepato-biliary pancreatic diseases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016341

Enrollment

500

Registered

2015-03-01

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobliary-pancreatic diseases

Interventions

Laparoscopic surgery Open surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 2) PS:0-1 3) Neutrophil >= 1,000 /mm3 Platelet >= 50,000 /mm3 Hb >= 8.0 g/dL AST and ALT =< 400 U/L Bilirubin =< 3.0 mg/dL creatinin =< 2.0 mg/dL 4) written informed consent

Exclusion criteria

Exclusion criteria: 1) R2 resection 2) Small remnant liver (estimated liver volume < 30%) 3) Others

Design outcomes

Primary

Measure	Time frame
Positivity of tumor marker expressing cells in blood and drain discharge, evaluation of cut-surface, and difference in preoperative treatment.	—

Countries

Japan

Contacts

Public ContactShogo Kobayashi

Osaka Medical Center for Cancer and Cardiovascular diseases Surgery

s-kobayashi@umin.ac.jp06-6972-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026